All medicines have benefits and potential risks. Onxeo has the responsibility, for the sake of patient safety:
The Pharmacovigilance of Onxeo ensures continuous monitoring for adverse effects of drugs. Risk situations are monitored carefully such as misuse, abuse, overdose, medication errors and the use during pregnancy or while breastfeeding.
Onxeo’s Pharmacovigilance Department is working in close collaboration with health professionals, competent health authorities (national health agencies such as the ANSM), the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA) and the patient community, in order to prevent and reduce risks to patient safety and optimise the risk/benefit ratio of its medicines.
The Pharmacovigilance Department also has the responsibility of informing physicians and patients about any potential risks associated with a drug.
In order to fulfil its mission, Onxeo needs to gather all available information on its medicines:
To report a case of pharmacovigilance, you can reach us: